Humana Inc. – Investment Performance and Market Position
Stock Performance Over the Past Year
On 30 October 2025 the Humana share closed at $278.19. The most recent closing price reported on 31 October 2025 was $285.61. When comparing the share price from 30 October 2024, which was $257.83, to the 31 October 2025 value, a hypothetical investment of $1,000 made on that earlier date would have grown to $1,107.75. This represents a gain of 10.77 % over the one‑year period. The calculation excludes any effects of share‑splits or dividend distributions.
Company Overview
Humana Inc. is a managed health‑care provider headquartered in Louisville, United States. It operates in the Health Care sector through health‑maintenance organizations, point‑of‑service plans, and administrative‑services products. The company serves employer groups, government‑sponsored plans, and individuals. Humana trades on the New York Stock Exchange under the ticker HUM and had an IPO on 22 January 1993. As of 30 October 2025, its market capitalization was $34.35 billion and the price‑to‑earnings ratio stood at 21.92.
Recent Market Context
The 52‑week high for Humana reached $315.35 on 4 September 2025, while the 52‑week low was $206.87 on 17 July 2025. The company’s recent stock price of $285.61 places it comfortably between these extremes, indicating a relatively stable performance within the current year.
Conclusion
Humana’s share price has delivered a modest but positive return to investors over the last twelve months, with the stock trading near the upper half of its 52‑week range. The company’s established presence in the managed‑care market, combined with its sizable market capitalization and competitive price‑earnings multiple, suggests continued relevance within the Health Care sector.
